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Cytomegalovirus(CMV)infections arecontrolled bytheimmune system and lead
to virallatency (1) in the immunocompetent host. Onlyin the immunocompromised
host do primary as well as recurrent infections cause fatal disease. Congenital infec-
tion is responsible for severe fetal malformation (2, 3), and interstitial CMV pneu-
monia is considered the main reason for mortality in leukemia patients irradiated
for bone marrow transplantation (4). Manifestations of CMV disease have been
reported as episymptoms of AIDS, frequently representing the immediate cause of
death after immunosuppression by HIV (5).
Wehave previously describedan animal model forthe study ofCMV disease in the
whole-body -y-irradiated host, the infection ofmice with murine CMV (MCMV)'.
By adoptive cell transfer, protectionagainstacute MCMVdisease proved afunction
ofspecifically sensitized effector T lymphocytes ofthe CD8 subset, whereas T lym-
phocytes of the CD4 subset were dispensable for short-term immunocytotherapy
(6-9). The CD8+ effector cells prevented the lethal bone marrow aplasia caused by
a virus-induced failure in hemopoietic stem cell generation (10), and also prevented
tissue lesions by controlling the spread ofvirus (8). The immunodominant antigen
recognized by protective, antiviral CD8+ T lymphocytes could be identified as a
family ofpeptides derived from pp89, the major immediate-early phase protein en-
coded by MCMV (11-17).
Theconditions for superimposed CMV disease during HIV infectiondiffer from
those in bone marrow transplant recipients in that the immunosuppression selec-
tively affects the CD4+ T lymphocytes, while sparingthe CD8+ T lymphocytes (18).
It was therefore ofinterest to explore to what extent the residual CD8 subset can
control CMV infection on its own. Recent reports have given examples for an au-
tonomy in vivo of the CD8 subset in viral infection models involving a depletion
ofthe CD4 subset (19-22), which implies that cooperation of CD4+ helper T lym-
phocytes is not essential for initiating a CD8 subset-mediated immune response.
Whether such a response canlast long enough to also maintain along-term control
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of a persistent or latent CMV infection, was, however, still open to question. In this
communication, as a model for CMV disease in the CD4 subset-deficient host, the
course of MCMV infection was studied in mice that were long-term depleted of
the CD4 subset with anti-CD4 mAb administered repeatedly. We report that, even
though the clearance of replicating virus in host tissues was delayed, protective
CD8+ effector cells were generated and finally restricted persistent virus multipli-
cation to acinar glandular epithelial cells of the salivary glands .
Materials and Methods
Elimination ofTLymphocyteSubsets In Vivo.
￿
8-wk-old female BALB/c mice, bred under specific
pathogen-free conditions, were depleted of T lymphocyte subsets according to the protocol
established by Cobbold et al. (23). Long-term depletion of the CD4 subset was accomplished
by weekly intravenous infusions (for time schedule see Fig. 1) of N1 mg ofrat IgG2b antimu-
rine CD4 mAb GK1.5 (24, 25) dissolved in 0 .5 ml of PBS, and the CD8 subset was depleted
by a single infusion of the same amount of rat IgG2b antimurine CD8 mAb YTS-169.4 (23).
The antibodies were partially purified by precipitation with 50% ammonium sulfate from
the ascites of BALB/c mice bearing the respective hybridomas. After dialysis against PBS,
the amount of specific antibody in the ascites protein was determined by a radial im-
munodiffusion assay using rat IgG standards (Serotec, Oxxon, England) .
Virus and Infection Conditions.
￿
Sucrose gradient-purified, mouse embryo fibroblast culture-
propagated MCMV (Smith strain, code VR194; American Type Culture Collection, Rock-
ville, MD) was used for intraplantar infection. The dose of infection was 2 x 105 plaque-
forming units (PFU) throughout. CD4 subset-depleted mice were infected at the day after
the first infusion of antibody, and recipients for the adoptive transfer were infected tit h after
y irradiation and cell transfer.
Adoptive TLymphocyte Transfer.
￿
A prophylactic adoptive transfer was performed as described
previously (6-9). In brief, recipient mice were immunodepleted by total-body 'y irradiation
with 6 Gy delivered as a single dose at a rate of 1 .325 Gy/min. Nylon wool-purified spleen
T lymphocytes or subsets thereof, derived by in vitro depletion with antibody (GK1 .5 and
YTS-169.4 for depleting the CD4 and CD8 subset, respectively) and rabbit complement, were
infused into the tail vein ti4 h after irradiation and 2 h before infection. Virus titers in tissues
of the recipients were determined 2 wk later.
Virus Titers in Tissues.
￿
Infectious MCMV in tissues was quantitated by a plaque assay
(6). The detection limit was 100 PFU ofMCMV per organ homogenate. The pooled parotid,
greater sublingual, and mandibular glands are collectively referred to as salivary glands. Sets
of virus titers are regarded as significantly different for p < a = 0.05 (one sided), where P
denotes the observed probability value, and a denotes the selected significance level
(distribution-free Wilcoxon-Mann-Whitney exact rank sum test).
Detection of Virus-specificAntibodies.
￿
The ELISA for quantitating MCMVspecific antibodies
in sera by using ultrasonicated, infected mouse embryo fibroblasts as source of antigen has
been described in detail previously (16). Titers were read from the half-maximal OD after
subtraction of values obtained when, for control, the lysate of noninfected fibroblasts was
used for coating the microdilution plates. The specificity of the sera was independently con-
trolled by the immunoprecipitation of MCMVspecific proteins (12).
Cytofluorometric Ana4ysis.
￿
For single-parameter cytofluorometric analysis (FRCS IV; Becton
Dickinson & Co., Sunnyvale, CA) of the distribution of the CD4 and CD8 subsets, T lym-
phocytes were stained indirectly with mAb GK1 .5 and YTS-169.4, respectively, using fluores-
cein (FITC)-conjugated affinity-purified F(ab')2 fragments of goat anti-rat IgG (Jackson Im-
muno Research, Avondale, PA) as second reagent. The fluorescence signal was triggered on
particles larger than platelets, and propidium iodide (2 Fig/ml) -stained dead cells were ex-
cluded by electronic gating. Relative fluorescence intensities were expressed on a log scale,
with 104 cells analyzed.
Histology.
￿
Forlight microscopy, mandibular glands were fixed with Bouin's fixative. Tissue
samples were embedded in paraffin, and thin sections (5 jm) were stained with hematoxylinand eosin. For EM, fixation was performed with 2.5 % glutaraldehyde in 0.1 M sodium caco-
dylate buffer (pH 7 .2). After postfixation in 17o osmium tetroxide, tissue blocks were em-
bedded in Araldite". Semithin sections (1 Etm) were stained with toluidine blue to select sites
of interest by light microscopy. Ultrathin sections (70 nm) from selected sites were stained
with uranyl acetate and lead citrate, and were examined with an electron microscope(model
109; Carl Zeiss, Inc., Thornwood, NY).
Results
Experimental Design.
￿
The time schedule for the treatments and assays is outlined
in Fig. 1 to explain the experimental concept. It was the intention to study the au-
tonomous contribution ofthe CD8 subset ofT lymphocytes to the long-term control
of a CMV infection. The problem falls into two main questions: first, can antiviral
effector cells be generated from their precursors in the absence of CD4+ helper T
lymphocytes; and second, if so, is this response lasting and can it maintain a long-
term control of a persistent infection in the absence of antiviral antibody?
To address both questions in the same experiment, BALB/c mice were already
depleted ofthe CD4 subset before the infection, and the state ofselective CD4 subset
deficiency was then maintained throughout the observation period of 10 wk. The
efficacy of depletion was controlled quantitatively by cytofluorometric analysis of
the distribution of T lymphocyte subpopulations in lymphoid tissues. One has to
bear in mind, however, that cytofluorography can give us only snapshots of the com-
position of the T lymphocyte population and only at sites selected for testing. Since
in vivo depletion of the CD4 subset has been shown to prevent the generation of
antibodies (19-23, 25, 26), monitoring of seroconversion provides a sensitive and
location-independent meansfor controlling an enduring functional depletion ofhelper
T lymphocytes. Both approaches in combination should thus give reliable informa-
tion on the completeness of depletion.
The generation ofantiviral effector cells in infected, CD4 subset-depleted, as well
as nondepleted, mice was tested by adoptive transfer of T lymphocytes from donors
of the respective groups into syngeneic recipient mice that were immunodepleted
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by-y irradiation. This regimen has been worked out previouslyto amodel forcytoim-
munotherapy ofCMV disease (6-10). The control ofviral spread in tissues of the
recipients proved a function of the number oftransferred CD8' antiviral effector
cells and was neither dependent upon nor influenced by a cotransfer ofCD4+ T
lymphocytes (6-10) . Adoptive transfer can therefore also be used as an in vivo assay
for estimating the strength of the CD8 subset-mediated antiviral immunity estab-
lished in the donor mice.
The state ofMCMV disease in CD4 subset-depleted mice and, for control, in
nondepleted mice, wasfollowed by screening virusproduction intissuesofindividual
probands collected randomly from the respective sample.
Induction of a CD4- CD8- Subset by In Vivo Depletion of the CD4 Subset.
￿
In accord
with the description of the in vivo depletion method for T lymphocyte subsets by
Cobbold et al. (23) and Wofsy et al. (25), intravenous infusion ofthe rat antimurine
CD4 mAb GK1.5 caused a rapid and complete depletion ofCD4+ T lymphocytes
in lymph nodes (not shown) and spleen (Fig. 2, top and center), so that at the time
of infection (Fig. 1), the T lymphocyte population consisted entirely of CD8+ T
lymphocytes (Fig. 2, center). To maintain the state of CM subset deficiency, the
depleting antibody was administered weekly. When after 6 wk the composition of
nylonwool-purified splenic Tlymphocytes was controlled again; continuedabsence
ofCD4+ T lymphocytes could be confirmed, but in addition to the expected CD8
subset, a double-negative CD4- CD8- subset was then detected (Fig. 2, bottom).
Only recently has this phenomenon been described (27), and ithasbeenoverlooked
in previous reports on the in vivo autonomy ofthe CD8 subset. In light ofthe pres-
ence ofa population of as yet undefined function, the role of CD8+ T lymphocytes
in the CD4 subset-deficient host has to be critically re-evaluated.
The Production ofAntiviralAntibodies Requires Help by theCD4Subset.
￿
Previous reports
have alreadygivenexamples forthe prevention ofantibodyresponsesby invivo deple-
tion of the CD4 subset (19-23, 25, 26). This also holds true for the antibody re-
sponse to MCMV (Table I). When tested 6 and 10 wk after infection, seroconver-
sionin immunocompetent mice became evident from high MCMVspecific antibody
titers, whereas mice depleted of the CD4 subset mostly remained seronegative or
at best developed a marginal antibody titer. Three conclusions can be drawn: first,
the invivo Blymphocyte response to MCMVis asstrictly dependentupon thecooper-
ation with T lymphocytes of the CD4 subset as has been seen with other antigens.
Second, the in vivo depletion ofthe CD4 subset in our experiments was complete
and lasting enough for long-term prevention of an antibody response. Third, the
observed failure in antibody production implies that the newly arising CD4-CD8-
lymphocytes do not substitute for CD4+CD8- T lymphocytes in providing help to
B lymphocytes.
Presence ofAntiviral CD8+ Effector Cells in Long-term CD4 Subset-depletedMice.
￿
Lym-
phocyte transfer into lethally infected recipient mice was used as an in vivo assay
for testing the presence and efficacy ofprotective, antiviral effector cells within the
CD8 subset ofT lymphocytes from donors 6 wk after infection. Splenic T lympho-
cytes were isolated by nylonwool purification and were depleted in vitro oftheCD4
subset to make also formally sure that the assay was not influenced by CD4' helper
T lymphocytes. Virus replication in tissues of the recipients is shown representa-
tively for thelungs as indicatorsite (Fig. 3), with similardatadetermined forspleen
and adrenal glands (not shown).Immunocompetent
Long-term
C134-subset depleted
Short-term
CD4-subset depleted
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Tlymphocyte subpopulations after in vivo depletion ofthe CD4subset. Cytofluoro-
metric analysis comparing the distribution ofT lymphocyte subpopulations in immunocompe-
tent mice (upper row), in mice 1 d after infusion of aCD4 mAb (center row), and in mice after
weekly infusions ofaCD4 mAb for a period of 6wk (lower row). Fluorescence profiles seen after
staining of the CD8 subset (left column) and of the CD4 subset (right column) are depicted with
solid lines. The control profiles obtained with the FITC-conjugated second reagent alone are
shown superimposed with dashed contours.
TABLE I
Absence of MCMV-specific Antibody in CD4 Subset-depleted,
Persistently Infected Mice
CM
' Serum was taken from individual mice for which the virus titers in tissues were
determined at 6 wk postinfection (see Fig. 3) and at 10 wk postinfection (see
Table II), respectively.
t MCMV-specific antibodies were determined by ELISA. Data represent the
reciprocal of the serum dilution that gave half-maximal activity.
Weeks
postinfection ceCD4 in vivo
Proportion of
seropositive mice'
Antibody titer in
seropositive micet
6 - 4:4 2,560-5,120
6 + 2:9 <10
10 - 6:6 2,560-10,240
10 + 1:5 <101204
￿
CYTOMEGALOVIRUS INFECTION DURING CD4 SUBSET DEFICIENCY
e
a
0 5 m
m
-' a
a
- 3
2
FIGURE 3. Detection of an-
tiviral CD8* effector cells in
CD4 subset-depleted mice.
Nylon wool-purified splenic T
Donor
￿
Noninfected
￿
Infected
￿
C134-depleted & infected
￿
lymphocytes were depleted in
re-y"
￿
c~ w-cw'
￿
c
r
w-Coe' ~
r w- Cw""-'
￿
CwCne-
￿
vitro of the CD4 subset and
CD4-CDe
￿
transferred into immunode-
pleted recipient mice forthe in
vivo assessment of theantiviral
activity of the CD8 subset of
donormice. Titers in individual
recipients, measured 2 wk after
transfer and infection, are
signified by closed circles, and
median values are marked by
horizontal bars. The detection
limit (DL) is indicated by the
dashed line. (A)Donors nonin-
fected;(B)donors infected 6wk
DL
￿
----------------------------------------------
￿
before; (C) donors depleted of
e
￿
c
￿
D
￿
the CD4 subset 1 d before in-
4 5
￿
4 5
￿
, 4 5 .
￿
4 5
￿
fection and maintained CD4
Number of donor T lymphocytes llogtol
￿
subset deficient by weekly infu-
sions of aCD4 mAb for 6 wk;
(D)Tlymphocytes derived from
groupC donors anddepleted in
vitro of the CD8 subset.
The difference between the virus titers seen after transfer of nonprimed CD8+
Tlymphocytes isolated from noninfected, immunocompetent donors (Fig. 3, A) and
thoseseenwithinfected, immunocompetent mice as donors (Fig. 3, B), is a measure
ofthe antiviral response ofthe CD8 subset in the presence ofthe CD4 subset (com-
pareA and B;p = 0.005). In the absence ofthe CD4 subset (Fig. 3, C) the antiviral
response of the remaining T lymphocytes reached the same strength (compare B
and C; p > 0.1). Since, however, after long-term depletion of the CD4 subset, the
lymphocyte population was composed of a CD8 subset and of a new subset with
the phenotype CD4-CD8- (recall Fig. 2), it became necessary to also consider the
possibility that the antiviral function was performed by this new subset and not,
as one would anticipate from published experience (19-22), by CD8' effector cells
generated independently ofthe CD4 subset. Elimination in vitro ofthe CD8 subset
and transfer of the resulting purified CD4-CD8- population (Fig. 3 D) confirmed
that, also in a state of CD4 subset deficiency, all antiviral effector cells belong to
the CD8 subset (Fig. 3, compare C and D; p = 0.005).
Two conclusions can be drawn: first, an antiviral immune response by the CD8
subset canbe initiated and maintainedwithoutthe helpprovidedby theCD4 subset;
and second, the CD4- CD8- subset has no antiviral function.
DelayedClearance ofInfectious Virusin Tissues of CD4 Subset-depletedMice.
￿
The state
ofdisease in CD4 subset-depleted mice and in immunocompetent mice was com-
pared by quantitating virus in tissues at 6 wk after the infection (Fig. 4). In im-
munocompetentmice, virus spread was controlled bythat time inlungsand spleen,
and in the salivary glands, which are known as a preferred site ofCMV replication
(6-8, 28); virus was detected in only two offour mice, and then only with low titers.
In the spleen ofCD4 subset-depleted mice, which is at the site at which presenceu. a
0
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FIGURE 4.
￿
Effect of CD4 subset depletion on the course of in-
fection. A comparison is made at 6 wk postinfection between
the virus production in tissues of long-term CD4
subset-deficient mice andimmunocompetent mice. Individu-
ally scored titers are shown by closed circles, andmedian values
are marked by horizontal bars. The dashed line indicates the
detection limit.
of antiviral CD8+ effector cells could be demonstrated (recall Fig. 3), in six ofnine
mice, virus multiplication wasalso prevented, whereas inlungs and in salivary glands,
the production of infectious virus continued. The wide range ofvirus titers seen
forthe lungs suggested that in this tissue, antiviral effector cells were operatingwith
different efficacy among individual mice. The prolonged phase of virus replication
was not associated with any sign of disease. One could think that the absence of
antiviral antibody in CD4 subset-depleted mice (Table I) was reponsible for en-
during virus production in lungs and salivary glands. It is therefore worth recalling
that strikingly similar observations were made 2 mo after successful cytoim-
munotherapy of lethal MCMV disease in -y-irradiated mice, even though in that
situation all mice were seropositive as a result of autoreconstitution (8).
Cell Type-restrictedPersistent Infection in Salivary Gland Tissue.
￿
1 mo later, by 10 wk
aftertheinfection, virusreplication had ceased inthelungs notonly ofimmunocompe-
tent mice (Table II, group A), but also of CD4 subset-depleted mice, whereas in
TABLE II
Control of Site-restricted Persistent Infection by Antiviral
Elector Cells of the CD8 Subset
' Depletion with uCD4 mAb GK1.5 started at the day before infection andwas
continued by weekly administration ofantibody (Fig. 1). Depletion ofthe CD8
subset wasaccomplished by infusion of ceCD8 mAb YTS-169.4 at 8wk postin-
fection, which is 2 wk before the determination of virus titers.
1 Proportion of mice with infectious virus in the indicated tissue.
Range of virus titers (loglo PFU).
Group
In vivo
otCD4
depletion'
ctGD8 Salivary
Detection of
(10 wk
glands
virus in
postinfection)
tissue
Lungs
A - - 3:6;1 3 .4-3.94 0:6
B + - 5:5; 5 .4-6.3 0:5
C + + 6:6; 6.3-6.8 6:6; 2.3-3 .6FIGURE 5 .
￿
Histology of a persistently infected salivary gland . Mandibular gland specimens were
taken at 10 wk postinfection, which is during the period o£ persistent infection, from CD4
subset-depleted mice . (a) Examination by light microscopy (bar; 20Am) : (A) acinus; (D) interca-
lated duct in longitudinal section . A glandular epithelial cellwith an intranuclear inclusion char-
acteristic ofCMV infection is seen located in one of the acini (arrow) . The surrounding tissue
does not show histopathologic changes . (b and c) Examination by EM (bars, 2 'Um and 200 nm,
respectively) : (b) infected acinar glandular epithelial cell with an intranuclearinclusion body com-
posed ofreticularlyarranged amorphous material surrounded by nucleocapsids . Largecytoplasmic
vacuoles, oriented towards excretion ducts, are filled with high numbers (-1,000) ofvirions. Inset
(c), content of a cytoplasmic vacuole at high magnification, demonstrating the presence exclu-
sively of monocapsid virions .JONJIC ET AL.
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the salivary glands virus production continued without decline (Table 11, group B).
In face of a permanent risk of re-infection by hematogenous spread of salivary
gland-derived virus, it is remarkable that the lungs remained free of virus in spite
of the absence of antibody (recall Table I). It was therefore asked whether the CD8
subset was required for the site restriction of the infection. Depletion of the CD8
subset in the long-term CD4 subset-depleted mice led to continued virus produc-
tion in the lungs (Table II, group C), and thus proved that restriction of the infection
to the salivary glands in persistently infected mice is a function of antiviral CD8+
effector cells.
We then studied the histological basis of the persistent infection in salivary gland
tissue (Fig. 5). It was known before that in immunocompetent mice MCMV repli-
cates without tissue damage in glandular epithelial cells of salivary gland tissue (29),
whereas in -y-irradiated, immunodepleted mice, infection ofconnective tissue fibro-
blasts was also observed (F. Weiland, unpublished observations). As it has been de-
scribed for embryo fibroblasts in vitro (30) and for interstitial lung fibroblasts (6),
as well as for adrenal cortical parenchymal cells (9) in vivo, the morphogenesis of
MCMV in salivary gland fibroblasts is characterized by the formation ofmulticapsid
virions. During persistent infection in CD4 subset-deficient mice, infected fibro-
blasts and tissue lesions were not observed. Virus production was restricted to a low
number of glandular epithelial cells (Fig. 5 a). The morphogenesis of MCMV is
special in glandular epithelial cells in that high numbers exclusively of monocapsid
virions are released from large cytoplasmic vacuoles (Fig. 5, b and c) (estimated 1,000
virions per vacuole, which is in the order of 104/cell), which explains the high virus
titers observed in salivary glands despite the low number of infected cells. From the
lack ofinfected fibroblasts in CD4 subset-depleted mice along with the observation
of an increase in virus titers after depletion of the CD8 subset (Table 11; compare
groups B and C, significant with p = 0.005), we conclude that salivary gland tissue
is accessible to antiviral control by CD8+ effector cells, and that persistent CMV
infection of the host is based on an as yet undefined but selective immune escape
mechanism characteristic of glandular epithelial cells.
Discussion
The aim of this study was to investigate whether in a state of selective CD4 subset
deficiency the residual CD8 subset can control a CMV infection on its own, and
how the course of infection, which is the succession of acute phase, persistent phase,
and latent phase of infection, is altered in the absence of the CD4 subset.
It was known before from our own studies that the antiviral effector cells that pro-
tect against murine CMV disease belong to the CD8 subset (6-10, 16). The question
to be answered was, therefore, whether the antiviral response of this subset can be
initiated and also maintained long enough for controlling the infection without help
delivered by the CD4 subset. We could add a new example to the increasing evi-
dence that CD4' helper T lymphocytes are not essential for initiating a CD8
subset-mediated response in vivo (19-22, 31, 32), and, in addition, the data affirmed
that the antiviral function of the CD8 subset in CD4 subset-depleted mice is not
rapidly exhausted, but is enduring. Yet, the proposed autonomy in vivo of the CD8
subset is not proven by these findings, because a CD4- CD8 - subset of as yet1208
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undefined function was seen to have accumulated in the spleen in response to the
depletion of the CD4 subset.
In lymphoid tissues ofimmunocompetent mice, as well as ofhumans, CD4-CD8-
T lymphocytes are rare, but this subset was found amplified in states ofdefective
T lymphocyte maturation or immunodeficiency (33, 34), and, specifically, an ac-
cumulation of Thy-1+CD4- CD8- T lymphocytes in the spleen was seen also in
mice depleted ofthe CD4 subset by infusion ofoiCD4 antibody(27). It isnowestab-
lished that T lymphocytes ofthis subset express a TCR-y/S (35-38) and are capable
ofperforming nonrestricted (39, 40) as well as MHC-linked specific cytolytic func-
tions (41, 42).
A role for this subset in the control ofviral diseases was not yet explored. The
fact that a CD4- CD8- subset accumulated after selective depletion of the CD4
subset also in the spleen ofmice that were persistently infected with MCMVprovided
an excellent model forstudyingthecontribution ofthissubset to antiviral immunity
over a long period oftime. Two definite conclusions can be made: first, CD4-CD8-
T lymphocytes do not substitute for the depleted CD4 subset in providing help to
B lymphocytes; and, second, upon adoptive transfer, CD4-CD8- T lymphocytes
generated ininfected mice donot function asantiviral effector cells controllingvirus
production intissues. Since, however, specific in vivodepletionofthis subset orpreven-
tion ofits generation is technically not feasible as yet, a role for CD4- CD8- T lym-
phocytes in maintaining the antiviral response ofthe CD8 subset is not excluded,
and this implies that an autonomy of the CD8 subset is not proved.
Even though virusproduction finallyceased inspleen and lungsunder theinfluence
of the antiviral function of CD8+ effector cells, the control of acute infection was
delayedin CD4 subset-deficient mice. It could bedemonstrated that at atime when
the spleen was clearedin both theimmunocompetent and the CD4 subset-depleted
mice, the antiviralefficacy oftheCD8 subset recovered from the spleen wasthe same
in both groups of mice, as assessed by adoptive transfer. Our previous studies did
not give any indication of a direct antiviral function ofthe CD4 subset (6-10), and
since prolonged virus production in the lungs was seen also inseropositive mice (8),
the absence of antibodies also does not offer the explanation for the delay in the
control of infection. It remains to be tested whether a role in vivo ofCD4+ helper
T lymphocytes could be to accelerate the clonal expansion of the antiviral CD8+
effector T lymphocytes or to facilitate their infiltration into nonlymphoid tissue. In
essence, it can be concluded that depletion of the CD4 subset affects, but does not
prevent the clearance of productive acute infection in vital tissues.
Whilein immunocompetent mice virallatencyis established, CD4subset-deficient
mice cannot eliminatevirus production in the salivary glands and thus remain per-
sistently infected. As opposed to the prolonged, but finally declining infection of
the lungs, the infection ofthe salivary glands wastruly persistent in thatvirus produc-
tion was undiminished over anobservation period of5 mo (not shown). Ifwe under-
standlatency in a clinical sense as a state ofdisease in which virus is not replicating
at any site, but can be induced to recurrence, then CD4 subset-deficient mice fail
toestablish latency. Yet, it would be incorrect to interpret this as a general incompe-
tence ofthe CD8 subset to aid the establishment ofa latent infection. There is evi-
dence for the spleen being a site ofMCMV latency (43-48); and the spleen was,JONJIC ET AL.
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in fact, the first tissue at which productive infection discontinued under the influence
of antiviral CD8+ effector cells.
The basis of the persistent infection in salivary gland tissue rather appears to be
an as yet undefined immune escape mechanism of acinar glandular epithelial cells.
In this cell type, MCMV replicates with a morphogenesis distinct from that seen
for other cell types (6, 9, 29, 30), and it can be speculated that viral antigen pro-
cessing and presentation may thus also differ.
In conclusion, our results in a model system for CMV disease have revealed that
a selective deficiency of the CD4 subset does not prevent the control ofCMV infec-
tion by antiviral effector cells of the residual CD8 subset.
Summary
We have established a murine model system for exploring the ability of a CD4
subset-deficient host to cope with cytomegalovirus infection, and reported three
findings. First, an antiviral response of the CD8 subset of T lymphocytes could be
not only initiated but also maintained for a long period of time despite a continued
absence of the CD4 subset, whereas the production of antiviral antibody proved strictly
dependent upon help provided by the CD4 subset .
Second, no function in the defense against infection could be ascribed as yet to
CD4 - CD8- T lymphocytes, which were seen to accumulate to a new subset as a
result of depletion of the CD4 subset. This newly arising subset did not substitute
for CD4+ T lymphocytes in providing help to B lymphocytes, and was also not
effective in controlling the spread of virus in host tissues. As long as a function of
these cells in the generation and maintenance of a CD8 subset-mediated response
is not disproved, caution is indicated with concern to an autonomy ofthe CD8 subset.
Third, even though with delay, the CD8+ effector cells raised in the CD4
subset-deficient host were able of clear vital tissues from productive infection and
to restrict asymptomatic, persistent infection to acinar glandular epithelial cells in
salivary gland tissue.
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